Global Antibody Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Antibody market size is predicted to grow from US$ 9853 million in 2025 to US$ 13580 million in 2031; it is expected to grow at a CAGR of 5.5% from 2025 to 2031.
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by Cйsar Milstein and Georges Kцhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Global Monoclonal Antibodies key players include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.
In terms of product, IgG is the largest segment, with a share about 80%. And in terms of application, the largest application is Research, followed by Therapeutic and Diagnostic.
LP Information, Inc. (LPI) ' newest research report, the “Antibody Industry Forecast” looks at past sales and reviews total world Antibody sales in 2024, providing a comprehensive analysis by region and market sector of projected Antibody sales for 2025 through 2031. With Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antibody industry.
This Insight Report provides a comprehensive analysis of the global Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antibody.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibody market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Antibody market?
What factors are driving Antibody market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antibody market opportunities vary by end market size?
How does Antibody break out by Type, by Application?
The global Antibody market size is predicted to grow from US$ 9853 million in 2025 to US$ 13580 million in 2031; it is expected to grow at a CAGR of 5.5% from 2025 to 2031.
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by Cйsar Milstein and Georges Kцhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Global Monoclonal Antibodies key players include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.
In terms of product, IgG is the largest segment, with a share about 80%. And in terms of application, the largest application is Research, followed by Therapeutic and Diagnostic.
LP Information, Inc. (LPI) ' newest research report, the “Antibody Industry Forecast” looks at past sales and reviews total world Antibody sales in 2024, providing a comprehensive analysis by region and market sector of projected Antibody sales for 2025 through 2031. With Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antibody industry.
This Insight Report provides a comprehensive analysis of the global Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antibody.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibody market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- IgM
- IgG
- IgA
- Other
- Therapeutic
- Research
- Diagnostic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Johnson and Johnson
- Merck
- Novartis
- AbbVie
- Amgen
- Pfizer
- Bayer
- Lilly
- Bristol-Myers Squibb
- GlaxoSmithKline
- Biogen
- AstraZeneca
- Sanofi
- Alexion Pharmaceuticals
- Seattle Genetics
What is the 10-year outlook for the global Antibody market?
What factors are driving Antibody market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antibody market opportunities vary by end market size?
How does Antibody break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antibody Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Antibody by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Antibody by Country/Region, 2020, 2024 & 2031
2.2 Antibody Segment by Type
2.2.1 IgM
2.2.2 IgG
2.2.3 IgA
2.2.4 Other
2.3 Antibody Sales by Type
2.3.1 Global Antibody Sales Market Share by Type (2020-2025)
2.3.2 Global Antibody Revenue and Market Share by Type (2020-2025)
2.3.3 Global Antibody Sale Price by Type (2020-2025)
2.4 Antibody Segment by Application
2.4.1 Therapeutic
2.4.2 Research
2.4.3 Diagnostic
2.5 Antibody Sales by Application
2.5.1 Global Antibody Sale Market Share by Application (2020-2025)
2.5.2 Global Antibody Revenue and Market Share by Application (2020-2025)
2.5.3 Global Antibody Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Antibody Breakdown Data by Company
3.1.1 Global Antibody Annual Sales by Company (2020-2025)
3.1.2 Global Antibody Sales Market Share by Company (2020-2025)
3.2 Global Antibody Annual Revenue by Company (2020-2025)
3.2.1 Global Antibody Revenue by Company (2020-2025)
3.2.2 Global Antibody Revenue Market Share by Company (2020-2025)
3.3 Global Antibody Sale Price by Company
3.4 Key Manufacturers Antibody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antibody Product Location Distribution
3.4.2 Players Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTIBODY BY GEOGRAPHIC REGION
4.1 World Historic Antibody Market Size by Geographic Region (2020-2025)
4.1.1 Global Antibody Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Antibody Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Antibody Market Size by Country/Region (2020-2025)
4.2.1 Global Antibody Annual Sales by Country/Region (2020-2025)
4.2.2 Global Antibody Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antibody Sales Growth
4.4 APAC Antibody Sales Growth
4.5 Europe Antibody Sales Growth
4.6 Middle East & Africa Antibody Sales Growth
5 AMERICAS
5.1 Americas Antibody Sales by Country
5.1.1 Americas Antibody Sales by Country (2020-2025)
5.1.2 Americas Antibody Revenue by Country (2020-2025)
5.2 Americas Antibody Sales by Type (2020-2025)
5.3 Americas Antibody Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibody Sales by Region
6.1.1 APAC Antibody Sales by Region (2020-2025)
6.1.2 APAC Antibody Revenue by Region (2020-2025)
6.2 APAC Antibody Sales by Type (2020-2025)
6.3 APAC Antibody Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antibody by Country
7.1.1 Europe Antibody Sales by Country (2020-2025)
7.1.2 Europe Antibody Revenue by Country (2020-2025)
7.2 Europe Antibody Sales by Type (2020-2025)
7.3 Europe Antibody Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antibody by Country
8.1.1 Middle East & Africa Antibody Sales by Country (2020-2025)
8.1.2 Middle East & Africa Antibody Revenue by Country (2020-2025)
8.2 Middle East & Africa Antibody Sales by Type (2020-2025)
8.3 Middle East & Africa Antibody Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antibody
10.3 Manufacturing Process Analysis of Antibody
10.4 Industry Chain Structure of Antibody
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antibody Distributors
11.3 Antibody Customer
12 WORLD FORECAST REVIEW FOR ANTIBODY BY GEOGRAPHIC REGION
12.1 Global Antibody Market Size Forecast by Region
12.1.1 Global Antibody Forecast by Region (2026-2031)
12.1.2 Global Antibody Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Antibody Forecast by Type (2026-2031)
12.7 Global Antibody Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Antibody Product Portfolios and Specifications
13.1.3 Roche Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Johnson and Johnson
13.2.1 Johnson and Johnson Company Information
13.2.2 Johnson and Johnson Antibody Product Portfolios and Specifications
13.2.3 Johnson and Johnson Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Johnson and Johnson Main Business Overview
13.2.5 Johnson and Johnson Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Antibody Product Portfolios and Specifications
13.3.3 Merck Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Antibody Product Portfolios and Specifications
13.4.3 Novartis Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 AbbVie
13.5.1 AbbVie Company Information
13.5.2 AbbVie Antibody Product Portfolios and Specifications
13.5.3 AbbVie Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 AbbVie Main Business Overview
13.5.5 AbbVie Latest Developments
13.6 Amgen
13.6.1 Amgen Company Information
13.6.2 Amgen Antibody Product Portfolios and Specifications
13.6.3 Amgen Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Amgen Main Business Overview
13.6.5 Amgen Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Antibody Product Portfolios and Specifications
13.7.3 Pfizer Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Bayer
13.8.1 Bayer Company Information
13.8.2 Bayer Antibody Product Portfolios and Specifications
13.8.3 Bayer Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bayer Main Business Overview
13.8.5 Bayer Latest Developments
13.9 Lilly
13.9.1 Lilly Company Information
13.9.2 Lilly Antibody Product Portfolios and Specifications
13.9.3 Lilly Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Lilly Main Business Overview
13.9.5 Lilly Latest Developments
13.10 Bristol-Myers Squibb
13.10.1 Bristol-Myers Squibb Company Information
13.10.2 Bristol-Myers Squibb Antibody Product Portfolios and Specifications
13.10.3 Bristol-Myers Squibb Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Bristol-Myers Squibb Main Business Overview
13.10.5 Bristol-Myers Squibb Latest Developments
13.11 GlaxoSmithKline
13.11.1 GlaxoSmithKline Company Information
13.11.2 GlaxoSmithKline Antibody Product Portfolios and Specifications
13.11.3 GlaxoSmithKline Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 GlaxoSmithKline Main Business Overview
13.11.5 GlaxoSmithKline Latest Developments
13.12 Biogen
13.12.1 Biogen Company Information
13.12.2 Biogen Antibody Product Portfolios and Specifications
13.12.3 Biogen Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Biogen Main Business Overview
13.12.5 Biogen Latest Developments
13.13 AstraZeneca
13.13.1 AstraZeneca Company Information
13.13.2 AstraZeneca Antibody Product Portfolios and Specifications
13.13.3 AstraZeneca Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 AstraZeneca Main Business Overview
13.13.5 AstraZeneca Latest Developments
13.14 Sanofi
13.14.1 Sanofi Company Information
13.14.2 Sanofi Antibody Product Portfolios and Specifications
13.14.3 Sanofi Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Sanofi Main Business Overview
13.14.5 Sanofi Latest Developments
13.15 Alexion Pharmaceuticals
13.15.1 Alexion Pharmaceuticals Company Information
13.15.2 Alexion Pharmaceuticals Antibody Product Portfolios and Specifications
13.15.3 Alexion Pharmaceuticals Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Alexion Pharmaceuticals Main Business Overview
13.15.5 Alexion Pharmaceuticals Latest Developments
13.16 Seattle Genetics
13.16.1 Seattle Genetics Company Information
13.16.2 Seattle Genetics Antibody Product Portfolios and Specifications
13.16.3 Seattle Genetics Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Seattle Genetics Main Business Overview
13.16.5 Seattle Genetics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Antibody Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Antibody Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of IgM
Table 4. Major Players of IgG
Table 5. Major Players of IgA
Table 6. Major Players of Other
Table 7. Global Antibody Sales byType (2020-2025) & (KG)
Table 8. Global Antibody Sales Market Share byType (2020-2025)
Table 9. Global Antibody Revenue byType (2020-2025) & ($ million)
Table 10. Global Antibody Revenue Market Share byType (2020-2025)
Table 11. Global Antibody Sale Price byType (2020-2025) & (USD/KG)
Table 12. Global Antibody Sale by Application (2020-2025) & (KG)
Table 13. Global Antibody Sale Market Share by Application (2020-2025)
Table 14. Global Antibody Revenue by Application (2020-2025) & ($ million)
Table 15. Global Antibody Revenue Market Share by Application (2020-2025)
Table 16. Global Antibody Sale Price by Application (2020-2025) & (USD/KG)
Table 17. Global Antibody Sales by Company (2020-2025) & (KG)
Table 18. Global Antibody Sales Market Share by Company (2020-2025)
Table 19. Global Antibody Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Antibody Revenue Market Share by Company (2020-2025)
Table 21. Global Antibody Sale Price by Company (2020-2025) & (USD/KG)
Table 22. Key Manufacturers Antibody Producing Area Distribution and Sales Area
Table 23. Players Antibody Products Offered
Table 24. Antibody Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Antibody Sales by Geographic Region (2020-2025) & (KG)
Table 28. Global Antibody Sales Market Share Geographic Region (2020-2025)
Table 29. Global Antibody Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Antibody Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Antibody Sales by Country/Region (2020-2025) & (KG)
Table 32. Global Antibody Sales Market Share by Country/Region (2020-2025)
Table 33. Global Antibody Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Antibody Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Antibody Sales by Country (2020-2025) & (KG)
Table 36. Americas Antibody Sales Market Share by Country (2020-2025)
Table 37. Americas Antibody Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Antibody Sales byType (2020-2025) & (KG)
Table 39. Americas Antibody Sales by Application (2020-2025) & (KG)
Table 40. APAC Antibody Sales by Region (2020-2025) & (KG)
Table 41. APAC Antibody Sales Market Share by Region (2020-2025)
Table 42. APAC Antibody Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Antibody Sales byType (2020-2025) & (KG)
Table 44. APAC Antibody Sales by Application (2020-2025) & (KG)
Table 45. Europe Antibody Sales by Country (2020-2025) & (KG)
Table 46. Europe Antibody Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Antibody Sales byType (2020-2025) & (KG)
Table 48. Europe Antibody Sales by Application (2020-2025) & (KG)
Table 49. Middle East & Africa Antibody Sales by Country (2020-2025) & (KG)
Table 50. Middle East & Africa Antibody Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Antibody Sales byType (2020-2025) & (KG)
Table 52. Middle East & Africa Antibody Sales by Application (2020-2025) & (KG)
Table 53. Key Market Drivers & Growth Opportunities of Antibody
Table 54. Key Market Challenges & Risks of Antibody
Table 55. Key IndustryTrends of Antibody
Table 56. Antibody Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Antibody Distributors List
Table 59. Antibody Customer List
Table 60. Global Antibody SalesForecast by Region (2026-2031) & (KG)
Table 61. Global Antibody RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Antibody SalesForecast by Country (2026-2031) & (KG)
Table 63. Americas Antibody Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Antibody SalesForecast by Region (2026-2031) & (KG)
Table 65. APAC Antibody Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Antibody SalesForecast by Country (2026-2031) & (KG)
Table 67. Europe Antibody RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Antibody SalesForecast by Country (2026-2031) & (KG)
Table 69. Middle East & Africa Antibody RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Antibody SalesForecast byType (2026-2031) & (KG)
Table 71. Global Antibody RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Antibody SalesForecast by Application (2026-2031) & (KG)
Table 73. Global Antibody RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Roche Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 75. Roche Antibody Product Portfolios and Specifications
Table 76. Roche Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Roche Main Business
Table 78. Roche Latest Developments
Table 79. Johnson and Johnson Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 80. Johnson and Johnson Antibody Product Portfolios and Specifications
Table 81. Johnson and Johnson Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Johnson and Johnson Main Business
Table 83. Johnson and Johnson Latest Developments
Table 84. Merck Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck Antibody Product Portfolios and Specifications
Table 86. Merck Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Merck Main Business
Table 88. Merck Latest Developments
Table 89. Novartis Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 90. Novartis Antibody Product Portfolios and Specifications
Table 91. Novartis Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Novartis Main Business
Table 93. Novartis Latest Developments
Table 94. AbbVie Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 95. AbbVie Antibody Product Portfolios and Specifications
Table 96. AbbVie Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. AbbVie Main Business
Table 98. AbbVie Latest Developments
Table 99. Amgen Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 100. Amgen Antibody Product Portfolios and Specifications
Table 101. Amgen Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Amgen Main Business
Table 103. Amgen Latest Developments
Table 104. Pfizer Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 105. Pfizer Antibody Product Portfolios and Specifications
Table 106. Pfizer Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Pfizer Main Business
Table 108. Pfizer Latest Developments
Table 109. Bayer Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 110. Bayer Antibody Product Portfolios and Specifications
Table 111. Bayer Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Bayer Main Business
Table 113. Bayer Latest Developments
Table 114. Lilly Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 115. Lilly Antibody Product Portfolios and Specifications
Table 116. Lilly Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Lilly Main Business
Table 118. Lilly Latest Developments
Table 119. Bristol-Myers Squibb Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 120. Bristol-Myers Squibb Antibody Product Portfolios and Specifications
Table 121. Bristol-Myers Squibb Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Bristol-Myers Squibb Main Business
Table 123. Bristol-Myers Squibb Latest Developments
Table 124. GlaxoSmithKline Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 125. GlaxoSmithKline Antibody Product Portfolios and Specifications
Table 126. GlaxoSmithKline Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. GlaxoSmithKline Main Business
Table 128. GlaxoSmithKline Latest Developments
Table 129. Biogen Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 130. Biogen Antibody Product Portfolios and Specifications
Table 131. Biogen Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Biogen Main Business
Table 133. Biogen Latest Developments
Table 134. AstraZeneca Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 135. AstraZeneca Antibody Product Portfolios and Specifications
Table 136. AstraZeneca Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 137. AstraZeneca Main Business
Table 138. AstraZeneca Latest Developments
Table 139. Sanofi Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 140. Sanofi Antibody Product Portfolios and Specifications
Table 141. Sanofi Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 142. Sanofi Main Business
Table 143. Sanofi Latest Developments
Table 144. Alexion Pharmaceuticals Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 145. Alexion Pharmaceuticals Antibody Product Portfolios and Specifications
Table 146. Alexion Pharmaceuticals Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 147. Alexion Pharmaceuticals Main Business
Table 148. Alexion Pharmaceuticals Latest Developments
Table 149. Seattle Genetics Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 150. Seattle Genetics Antibody Product Portfolios and Specifications
Table 151. Seattle Genetics Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 152. Seattle Genetics Main Business
Table 153. Seattle Genetics Latest Developments
LIST OFFIGURES
Figure 1. Picture of Antibody
Figure 2. Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antibody Sales Growth Rate 2020-2031 (KG)
Figure 7. Global Antibody Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Antibody Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Antibody Sales Market Share by Country/Region (2024)
Figure 10. Antibody Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of IgM
Figure 12. Product Picture of IgG
Figure 13. Product Picture of IgA
Figure 14. Product Picture of Other
Figure 15. Global Antibody Sales Market Share byType in 2025
Figure 16. Global Antibody Revenue Market Share byType (2020-2025)
Figure 17. Antibody Consumed inTherapeutic
Figure 18. Global Antibody Market:Therapeutic (2020-2025) & (KG)
Figure 19. Antibody Consumed in Research
Figure 20. Global Antibody Market: Research (2020-2025) & (KG)
Figure 21. Antibody Consumed in Diagnostic
Figure 22. Global Antibody Market: Diagnostic (2020-2025) & (KG)
Figure 23. Global Antibody Sale Market Share by Application (2024)
Figure 24. Global Antibody Revenue Market Share by Application in 2025
Figure 25. Antibody Sales by Company in 2025 (KG)
Figure 26. Global Antibody Sales Market Share by Company in 2025
Figure 27. Antibody Revenue by Company in 2025 ($ millions)
Figure 28. Global Antibody Revenue Market Share by Company in 2025
Figure 29. Global Antibody Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Antibody Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Antibody Sales 2020-2025 (KG)
Figure 32. Americas Antibody Revenue 2020-2025 ($ millions)
Figure 33. APAC Antibody Sales 2020-2025 (KG)
Figure 34. APAC Antibody Revenue 2020-2025 ($ millions)
Figure 35. Europe Antibody Sales 2020-2025 (KG)
Figure 36. Europe Antibody Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Antibody Sales 2020-2025 (KG)
Figure 38. Middle East & Africa Antibody Revenue 2020-2025 ($ millions)
Figure 39. Americas Antibody Sales Market Share by Country in 2025
Figure 40. Americas Antibody Revenue Market Share by Country (2020-2025)
Figure 41. Americas Antibody Sales Market Share byType (2020-2025)
Figure 42. Americas Antibody Sales Market Share by Application (2020-2025)
Figure 43. United States Antibody Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Antibody Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Antibody Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Antibody Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Antibody Sales Market Share by Region in 2025
Figure 48. APAC Antibody Revenue Market Share by Region (2020-2025)
Figure 49. APAC Antibody Sales Market Share byType (2020-2025)
Figure 50. APAC Antibody Sales Market Share by Application (2020-2025)
Figure 51. China Antibody Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Antibody Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Antibody Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Antibody Revenue Growth 2020-2025 ($ millions)
Figure 55. India Antibody Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Antibody Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Antibody Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Antibody Sales Market Share by Country in 2025
Figure 59. Europe Antibody Revenue Market Share by Country (2020-2025)
Figure 60. Europe Antibody Sales Market Share byType (2020-2025)
Figure 61. Europe Antibody Sales Market Share by Application (2020-2025)
Figure 62. Germany Antibody Revenue Growth 2020-2025 ($ millions)
Figure 63.France Antibody Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Antibody Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Antibody Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Antibody Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Antibody Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Antibody Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Antibody Sales Market Share by Application (2020-2025)
Figure 70. Egypt Antibody Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Antibody Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Antibody Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Antibody Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Antibody Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Antibody in 2025
Figure 76. Manufacturing Process Analysis of Antibody
Figure 77. Industry Chain Structure of Antibody
Figure 78. Channels of Distribution
Figure 79. Global Antibody Sales MarketForecast by Region (2026-2031)
Figure 80. Global Antibody Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Antibody Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Antibody Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Antibody Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Antibody Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antibody Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Antibody by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Antibody by Country/Region, 2020, 2024 & 2031
2.2 Antibody Segment by Type
2.2.1 IgM
2.2.2 IgG
2.2.3 IgA
2.2.4 Other
2.3 Antibody Sales by Type
2.3.1 Global Antibody Sales Market Share by Type (2020-2025)
2.3.2 Global Antibody Revenue and Market Share by Type (2020-2025)
2.3.3 Global Antibody Sale Price by Type (2020-2025)
2.4 Antibody Segment by Application
2.4.1 Therapeutic
2.4.2 Research
2.4.3 Diagnostic
2.5 Antibody Sales by Application
2.5.1 Global Antibody Sale Market Share by Application (2020-2025)
2.5.2 Global Antibody Revenue and Market Share by Application (2020-2025)
2.5.3 Global Antibody Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Antibody Breakdown Data by Company
3.1.1 Global Antibody Annual Sales by Company (2020-2025)
3.1.2 Global Antibody Sales Market Share by Company (2020-2025)
3.2 Global Antibody Annual Revenue by Company (2020-2025)
3.2.1 Global Antibody Revenue by Company (2020-2025)
3.2.2 Global Antibody Revenue Market Share by Company (2020-2025)
3.3 Global Antibody Sale Price by Company
3.4 Key Manufacturers Antibody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antibody Product Location Distribution
3.4.2 Players Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTIBODY BY GEOGRAPHIC REGION
4.1 World Historic Antibody Market Size by Geographic Region (2020-2025)
4.1.1 Global Antibody Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Antibody Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Antibody Market Size by Country/Region (2020-2025)
4.2.1 Global Antibody Annual Sales by Country/Region (2020-2025)
4.2.2 Global Antibody Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antibody Sales Growth
4.4 APAC Antibody Sales Growth
4.5 Europe Antibody Sales Growth
4.6 Middle East & Africa Antibody Sales Growth
5 AMERICAS
5.1 Americas Antibody Sales by Country
5.1.1 Americas Antibody Sales by Country (2020-2025)
5.1.2 Americas Antibody Revenue by Country (2020-2025)
5.2 Americas Antibody Sales by Type (2020-2025)
5.3 Americas Antibody Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibody Sales by Region
6.1.1 APAC Antibody Sales by Region (2020-2025)
6.1.2 APAC Antibody Revenue by Region (2020-2025)
6.2 APAC Antibody Sales by Type (2020-2025)
6.3 APAC Antibody Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antibody by Country
7.1.1 Europe Antibody Sales by Country (2020-2025)
7.1.2 Europe Antibody Revenue by Country (2020-2025)
7.2 Europe Antibody Sales by Type (2020-2025)
7.3 Europe Antibody Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antibody by Country
8.1.1 Middle East & Africa Antibody Sales by Country (2020-2025)
8.1.2 Middle East & Africa Antibody Revenue by Country (2020-2025)
8.2 Middle East & Africa Antibody Sales by Type (2020-2025)
8.3 Middle East & Africa Antibody Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antibody
10.3 Manufacturing Process Analysis of Antibody
10.4 Industry Chain Structure of Antibody
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antibody Distributors
11.3 Antibody Customer
12 WORLD FORECAST REVIEW FOR ANTIBODY BY GEOGRAPHIC REGION
12.1 Global Antibody Market Size Forecast by Region
12.1.1 Global Antibody Forecast by Region (2026-2031)
12.1.2 Global Antibody Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Antibody Forecast by Type (2026-2031)
12.7 Global Antibody Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Antibody Product Portfolios and Specifications
13.1.3 Roche Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Johnson and Johnson
13.2.1 Johnson and Johnson Company Information
13.2.2 Johnson and Johnson Antibody Product Portfolios and Specifications
13.2.3 Johnson and Johnson Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Johnson and Johnson Main Business Overview
13.2.5 Johnson and Johnson Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Antibody Product Portfolios and Specifications
13.3.3 Merck Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Antibody Product Portfolios and Specifications
13.4.3 Novartis Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 AbbVie
13.5.1 AbbVie Company Information
13.5.2 AbbVie Antibody Product Portfolios and Specifications
13.5.3 AbbVie Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 AbbVie Main Business Overview
13.5.5 AbbVie Latest Developments
13.6 Amgen
13.6.1 Amgen Company Information
13.6.2 Amgen Antibody Product Portfolios and Specifications
13.6.3 Amgen Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Amgen Main Business Overview
13.6.5 Amgen Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Antibody Product Portfolios and Specifications
13.7.3 Pfizer Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Bayer
13.8.1 Bayer Company Information
13.8.2 Bayer Antibody Product Portfolios and Specifications
13.8.3 Bayer Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bayer Main Business Overview
13.8.5 Bayer Latest Developments
13.9 Lilly
13.9.1 Lilly Company Information
13.9.2 Lilly Antibody Product Portfolios and Specifications
13.9.3 Lilly Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Lilly Main Business Overview
13.9.5 Lilly Latest Developments
13.10 Bristol-Myers Squibb
13.10.1 Bristol-Myers Squibb Company Information
13.10.2 Bristol-Myers Squibb Antibody Product Portfolios and Specifications
13.10.3 Bristol-Myers Squibb Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Bristol-Myers Squibb Main Business Overview
13.10.5 Bristol-Myers Squibb Latest Developments
13.11 GlaxoSmithKline
13.11.1 GlaxoSmithKline Company Information
13.11.2 GlaxoSmithKline Antibody Product Portfolios and Specifications
13.11.3 GlaxoSmithKline Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 GlaxoSmithKline Main Business Overview
13.11.5 GlaxoSmithKline Latest Developments
13.12 Biogen
13.12.1 Biogen Company Information
13.12.2 Biogen Antibody Product Portfolios and Specifications
13.12.3 Biogen Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Biogen Main Business Overview
13.12.5 Biogen Latest Developments
13.13 AstraZeneca
13.13.1 AstraZeneca Company Information
13.13.2 AstraZeneca Antibody Product Portfolios and Specifications
13.13.3 AstraZeneca Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 AstraZeneca Main Business Overview
13.13.5 AstraZeneca Latest Developments
13.14 Sanofi
13.14.1 Sanofi Company Information
13.14.2 Sanofi Antibody Product Portfolios and Specifications
13.14.3 Sanofi Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Sanofi Main Business Overview
13.14.5 Sanofi Latest Developments
13.15 Alexion Pharmaceuticals
13.15.1 Alexion Pharmaceuticals Company Information
13.15.2 Alexion Pharmaceuticals Antibody Product Portfolios and Specifications
13.15.3 Alexion Pharmaceuticals Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Alexion Pharmaceuticals Main Business Overview
13.15.5 Alexion Pharmaceuticals Latest Developments
13.16 Seattle Genetics
13.16.1 Seattle Genetics Company Information
13.16.2 Seattle Genetics Antibody Product Portfolios and Specifications
13.16.3 Seattle Genetics Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Seattle Genetics Main Business Overview
13.16.5 Seattle Genetics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Antibody Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Antibody Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of IgM
Table 4. Major Players of IgG
Table 5. Major Players of IgA
Table 6. Major Players of Other
Table 7. Global Antibody Sales byType (2020-2025) & (KG)
Table 8. Global Antibody Sales Market Share byType (2020-2025)
Table 9. Global Antibody Revenue byType (2020-2025) & ($ million)
Table 10. Global Antibody Revenue Market Share byType (2020-2025)
Table 11. Global Antibody Sale Price byType (2020-2025) & (USD/KG)
Table 12. Global Antibody Sale by Application (2020-2025) & (KG)
Table 13. Global Antibody Sale Market Share by Application (2020-2025)
Table 14. Global Antibody Revenue by Application (2020-2025) & ($ million)
Table 15. Global Antibody Revenue Market Share by Application (2020-2025)
Table 16. Global Antibody Sale Price by Application (2020-2025) & (USD/KG)
Table 17. Global Antibody Sales by Company (2020-2025) & (KG)
Table 18. Global Antibody Sales Market Share by Company (2020-2025)
Table 19. Global Antibody Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Antibody Revenue Market Share by Company (2020-2025)
Table 21. Global Antibody Sale Price by Company (2020-2025) & (USD/KG)
Table 22. Key Manufacturers Antibody Producing Area Distribution and Sales Area
Table 23. Players Antibody Products Offered
Table 24. Antibody Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Antibody Sales by Geographic Region (2020-2025) & (KG)
Table 28. Global Antibody Sales Market Share Geographic Region (2020-2025)
Table 29. Global Antibody Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Antibody Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Antibody Sales by Country/Region (2020-2025) & (KG)
Table 32. Global Antibody Sales Market Share by Country/Region (2020-2025)
Table 33. Global Antibody Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Antibody Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Antibody Sales by Country (2020-2025) & (KG)
Table 36. Americas Antibody Sales Market Share by Country (2020-2025)
Table 37. Americas Antibody Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Antibody Sales byType (2020-2025) & (KG)
Table 39. Americas Antibody Sales by Application (2020-2025) & (KG)
Table 40. APAC Antibody Sales by Region (2020-2025) & (KG)
Table 41. APAC Antibody Sales Market Share by Region (2020-2025)
Table 42. APAC Antibody Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Antibody Sales byType (2020-2025) & (KG)
Table 44. APAC Antibody Sales by Application (2020-2025) & (KG)
Table 45. Europe Antibody Sales by Country (2020-2025) & (KG)
Table 46. Europe Antibody Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Antibody Sales byType (2020-2025) & (KG)
Table 48. Europe Antibody Sales by Application (2020-2025) & (KG)
Table 49. Middle East & Africa Antibody Sales by Country (2020-2025) & (KG)
Table 50. Middle East & Africa Antibody Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Antibody Sales byType (2020-2025) & (KG)
Table 52. Middle East & Africa Antibody Sales by Application (2020-2025) & (KG)
Table 53. Key Market Drivers & Growth Opportunities of Antibody
Table 54. Key Market Challenges & Risks of Antibody
Table 55. Key IndustryTrends of Antibody
Table 56. Antibody Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Antibody Distributors List
Table 59. Antibody Customer List
Table 60. Global Antibody SalesForecast by Region (2026-2031) & (KG)
Table 61. Global Antibody RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Antibody SalesForecast by Country (2026-2031) & (KG)
Table 63. Americas Antibody Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Antibody SalesForecast by Region (2026-2031) & (KG)
Table 65. APAC Antibody Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Antibody SalesForecast by Country (2026-2031) & (KG)
Table 67. Europe Antibody RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Antibody SalesForecast by Country (2026-2031) & (KG)
Table 69. Middle East & Africa Antibody RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Antibody SalesForecast byType (2026-2031) & (KG)
Table 71. Global Antibody RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Antibody SalesForecast by Application (2026-2031) & (KG)
Table 73. Global Antibody RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Roche Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 75. Roche Antibody Product Portfolios and Specifications
Table 76. Roche Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Roche Main Business
Table 78. Roche Latest Developments
Table 79. Johnson and Johnson Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 80. Johnson and Johnson Antibody Product Portfolios and Specifications
Table 81. Johnson and Johnson Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Johnson and Johnson Main Business
Table 83. Johnson and Johnson Latest Developments
Table 84. Merck Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck Antibody Product Portfolios and Specifications
Table 86. Merck Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Merck Main Business
Table 88. Merck Latest Developments
Table 89. Novartis Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 90. Novartis Antibody Product Portfolios and Specifications
Table 91. Novartis Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Novartis Main Business
Table 93. Novartis Latest Developments
Table 94. AbbVie Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 95. AbbVie Antibody Product Portfolios and Specifications
Table 96. AbbVie Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. AbbVie Main Business
Table 98. AbbVie Latest Developments
Table 99. Amgen Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 100. Amgen Antibody Product Portfolios and Specifications
Table 101. Amgen Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Amgen Main Business
Table 103. Amgen Latest Developments
Table 104. Pfizer Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 105. Pfizer Antibody Product Portfolios and Specifications
Table 106. Pfizer Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Pfizer Main Business
Table 108. Pfizer Latest Developments
Table 109. Bayer Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 110. Bayer Antibody Product Portfolios and Specifications
Table 111. Bayer Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Bayer Main Business
Table 113. Bayer Latest Developments
Table 114. Lilly Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 115. Lilly Antibody Product Portfolios and Specifications
Table 116. Lilly Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Lilly Main Business
Table 118. Lilly Latest Developments
Table 119. Bristol-Myers Squibb Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 120. Bristol-Myers Squibb Antibody Product Portfolios and Specifications
Table 121. Bristol-Myers Squibb Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Bristol-Myers Squibb Main Business
Table 123. Bristol-Myers Squibb Latest Developments
Table 124. GlaxoSmithKline Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 125. GlaxoSmithKline Antibody Product Portfolios and Specifications
Table 126. GlaxoSmithKline Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. GlaxoSmithKline Main Business
Table 128. GlaxoSmithKline Latest Developments
Table 129. Biogen Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 130. Biogen Antibody Product Portfolios and Specifications
Table 131. Biogen Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Biogen Main Business
Table 133. Biogen Latest Developments
Table 134. AstraZeneca Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 135. AstraZeneca Antibody Product Portfolios and Specifications
Table 136. AstraZeneca Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 137. AstraZeneca Main Business
Table 138. AstraZeneca Latest Developments
Table 139. Sanofi Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 140. Sanofi Antibody Product Portfolios and Specifications
Table 141. Sanofi Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 142. Sanofi Main Business
Table 143. Sanofi Latest Developments
Table 144. Alexion Pharmaceuticals Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 145. Alexion Pharmaceuticals Antibody Product Portfolios and Specifications
Table 146. Alexion Pharmaceuticals Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 147. Alexion Pharmaceuticals Main Business
Table 148. Alexion Pharmaceuticals Latest Developments
Table 149. Seattle Genetics Basic Information, Antibody Manufacturing Base, Sales Area and Its Competitors
Table 150. Seattle Genetics Antibody Product Portfolios and Specifications
Table 151. Seattle Genetics Antibody Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 152. Seattle Genetics Main Business
Table 153. Seattle Genetics Latest Developments
LIST OFFIGURES
Figure 1. Picture of Antibody
Figure 2. Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antibody Sales Growth Rate 2020-2031 (KG)
Figure 7. Global Antibody Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Antibody Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Antibody Sales Market Share by Country/Region (2024)
Figure 10. Antibody Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of IgM
Figure 12. Product Picture of IgG
Figure 13. Product Picture of IgA
Figure 14. Product Picture of Other
Figure 15. Global Antibody Sales Market Share byType in 2025
Figure 16. Global Antibody Revenue Market Share byType (2020-2025)
Figure 17. Antibody Consumed inTherapeutic
Figure 18. Global Antibody Market:Therapeutic (2020-2025) & (KG)
Figure 19. Antibody Consumed in Research
Figure 20. Global Antibody Market: Research (2020-2025) & (KG)
Figure 21. Antibody Consumed in Diagnostic
Figure 22. Global Antibody Market: Diagnostic (2020-2025) & (KG)
Figure 23. Global Antibody Sale Market Share by Application (2024)
Figure 24. Global Antibody Revenue Market Share by Application in 2025
Figure 25. Antibody Sales by Company in 2025 (KG)
Figure 26. Global Antibody Sales Market Share by Company in 2025
Figure 27. Antibody Revenue by Company in 2025 ($ millions)
Figure 28. Global Antibody Revenue Market Share by Company in 2025
Figure 29. Global Antibody Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Antibody Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Antibody Sales 2020-2025 (KG)
Figure 32. Americas Antibody Revenue 2020-2025 ($ millions)
Figure 33. APAC Antibody Sales 2020-2025 (KG)
Figure 34. APAC Antibody Revenue 2020-2025 ($ millions)
Figure 35. Europe Antibody Sales 2020-2025 (KG)
Figure 36. Europe Antibody Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Antibody Sales 2020-2025 (KG)
Figure 38. Middle East & Africa Antibody Revenue 2020-2025 ($ millions)
Figure 39. Americas Antibody Sales Market Share by Country in 2025
Figure 40. Americas Antibody Revenue Market Share by Country (2020-2025)
Figure 41. Americas Antibody Sales Market Share byType (2020-2025)
Figure 42. Americas Antibody Sales Market Share by Application (2020-2025)
Figure 43. United States Antibody Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Antibody Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Antibody Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Antibody Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Antibody Sales Market Share by Region in 2025
Figure 48. APAC Antibody Revenue Market Share by Region (2020-2025)
Figure 49. APAC Antibody Sales Market Share byType (2020-2025)
Figure 50. APAC Antibody Sales Market Share by Application (2020-2025)
Figure 51. China Antibody Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Antibody Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Antibody Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Antibody Revenue Growth 2020-2025 ($ millions)
Figure 55. India Antibody Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Antibody Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Antibody Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Antibody Sales Market Share by Country in 2025
Figure 59. Europe Antibody Revenue Market Share by Country (2020-2025)
Figure 60. Europe Antibody Sales Market Share byType (2020-2025)
Figure 61. Europe Antibody Sales Market Share by Application (2020-2025)
Figure 62. Germany Antibody Revenue Growth 2020-2025 ($ millions)
Figure 63.France Antibody Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Antibody Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Antibody Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Antibody Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Antibody Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Antibody Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Antibody Sales Market Share by Application (2020-2025)
Figure 70. Egypt Antibody Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Antibody Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Antibody Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Antibody Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Antibody Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Antibody in 2025
Figure 76. Manufacturing Process Analysis of Antibody
Figure 77. Industry Chain Structure of Antibody
Figure 78. Channels of Distribution
Figure 79. Global Antibody Sales MarketForecast by Region (2026-2031)
Figure 80. Global Antibody Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Antibody Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Antibody Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Antibody Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Antibody Revenue Market ShareForecast by Application (2026-2031)
